Paydirt
RP
Insider

Richard K Prins

Director

Richard K Prins (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Amphastar Pharmaceuticals, Inc. (AMPH). The largest single filing was $162K of AMPH (7,973 sh × $20.30, as filed), executed Aug 11.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$275K
shares × price, as filed
Last traded
Aug 11
Filed Aug 12

Median ADV $12.0M across their filed names

Open performance
Volume by month
$438K$219K$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2024 · sells $244KDec 2024 · sells $438KNov 2025 · sells $113KAug 2026 · sells $162K
Buys $0 Sells $957K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
AMPH Amphastar Pharmaceuticals, Inc. AMPH · 0 buys · 4 sells 4 filings
Recent filings
AMPHSALE Amphastar Pharmaceuticals, Inc. View filing → $162K
7,973 sh × $20.30
Exec Aug 11
Filed Aug 12 · 6:14 PM ET
AMPHSALE Amphastar Pharmaceuticals, Inc. View filing → $113K
4,179 sh × $27.10
Exec Nov 25 2025
Filed Nov 25 2025 · 5:30 PM ET
AMPHSALE Amphastar Pharmaceuticals, Inc. View filing → $438K
10,000 sh × $43.77
Exec Dec 9 2024
Filed Dec 11 2024 · 5:30 PM ET
AMPHSALE Amphastar Pharmaceuticals, Inc. View filing → $244K
5,000 sh × $48.80
Exec Nov 12 2024
Filed Nov 13 2024 · 5:30 PM ET